Strengthening Alzheimer’s Disease Policy and Management in Asia Pacific: Pathways to Progress

Alzheimer’s disease is one of the fastest-growing health and social care challenges across Asia Pacific — yet policy readiness, diagnostic pathways, and care delivery remain uneven across the region.

This White Paper provides a structured, comparative view of how prepared health systems are to address Alzheimer’s disease today — and where urgent action is needed.

Covering nine APAC economies — Australia, China, Hong Kong, Japan, New Zealand, Singapore, South Korea, Taiwan, and Thailand — the report identifies critical system gaps, highlights differences in service readiness, and outlines opportunities for stronger, more coordinated policy responses.
 

Why it matters

Alzheimer’s disease is more than a clinical issue — it is a system-wide challenge affecting healthcare capacity, long-term care infrastructure, workforce readiness, and social support systems. Governments and healthcare leaders need clear, evidence-based insights to plan sustainable and equitable responses.

This White Paper supports:

• Policymakers shaping national dementia and ageing strategies
• Payers and health system leaders planning future service models
• Clinicians and care providers navigating evolving diagnostic and care pathways
• Advocacy and civil society organisations working to improve patient and caregiver outcomes

Read the White Paper and watch the webinar recording to gain insights on strengthening Alzheimer’s disease policy and care across Asia Pacific.